title: Bortezomib-induced skin lesion.
authors.affiliation: Institute of Oncology, Division of Hematology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey. mehmet.ozcan@deu.edu.tr
authors.forename: Mehmet Ali
authors.initials: MA
authors.lastname: Ozcan
authors.forename: Inci
authors.initials: I
authors.lastname: Alacacioglu
authors.forename: Ozden
authors.initials: O
authors.lastname: Piskin
authors.forename: Banu
authors.initials: B
authors.lastname: Lebe
authors.forename: Nurhilal
authors.initials: N
authors.lastname: Turgut
authors.forename: Selda
authors.initials: S
authors.lastname: Ceneli
authors.forename: Fatih
authors.initials: F
authors.lastname: Demirkan
authors.forename: Guner Hayri
authors.initials: GH
authors.lastname: Ozsan
authors.forename: Bulent
authors.initials: B
authors.lastname: Undar
mesh_terms: D000369:Aged, 80 and over; D001897:Boronic Acids / Q000009:adverse effects*; D000069286:Bortezomib; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D005260:Female; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy; D011719:Pyrazines / Q000009:adverse effects*
chemical_list: D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib